Science Explorer Back to mapMap
Discussion
Company · Cambridge · United States

Blueprint Medicines (United States)

World rank, all time
#19,502
of 34,923
Rank in United States
#4,047
of 7,310
Research works
199
▲ 33% vs 2018-21
Citations
8.5k
42.7 per fractional work
Top-10% rate
12.4%
all institutions 10.0%
vs its own fields
1.00×
1.00× is exactly expected
Open access
67%
world 40%
International
19%
world 18%

Which fields of science does Blueprint Medicines (United States) work in?

In 2022-now, 34% of research at Blueprint Medicines (United States) is in Health Sciences, 30% in Physical Sciences. Its largest fields are Medicine (33%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (10%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 36 fractional works · 34.2% of its workMedicine: 35 fractional works · 33.0% of its workPulmonary and Respiratory Medicine: 9 fractional works · 8.2% of its workPhysiology: 6 fractional works · 6.1% of its workOncology: 6 fractional works · 5.4% of its workRheumatology: 4 fractional works · 3.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.2% of its workGenetics: 1 fractional works · 1.1% of its workPathology and Forensic Medicine: 1 fractional works · 1.0% of its workPharmacology: 1 fractional works · 0.6% of its workGastroenterology: 1 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.6% of its workObstetrics and Gynecology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workDermatology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 1 fractional works · 1.1% of its workSpeech and Hearing: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.1% of its workPhysical Sciences: 32 fractional works · 29.9% of its workEngineering: 7 fractional works · 6.4% of its workAerospace Engineering: 2 fractional works · 2.0% of its workElectrical and Electronic Engineering: 2 fractional works · 1.7% of its workComputational Mechanics: 1 fractional works · 0.6% of its workSafety, Risk, Reliability and Quality: 1 fractional works · 0.5% of its workControl and Systems Engineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workMedia Technology: 0 fractional works · 0.3% of its workComputer Science: 6 fractional works · 6.1% of its workComputer Networks and Communications: 2 fractional works · 1.9% of its workInformation Systems: 1 fractional works · 1.3% of its workArtificial Intelligence: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 1 fractional works · 0.8% of its workComputer Vision and Pattern Recognition: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 5 fractional works · 5.0% of its workAtomic and Molecular Physics, and Optics: 3 fractional works · 2.5% of its workAstronomy and Astrophysics: 1 fractional works · 1.3% of its workCondensed Matter Physics: 1 fractional works · 1.3% of its workEnvironmental Science: 4 fractional works · 3.3% of its workEcology: 2 fractional works · 2.2% of its workManagement, Monitoring, Policy and Law: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 3 fractional works · 2.9% of its workEarth-Surface Processes: 1 fractional works · 1.3% of its workOceanography: 1 fractional works · 1.3% of its workAtmospheric Science: 0 fractional works · 0.4% of its workChemistry: 3 fractional works · 2.8% of its workOrganic Chemistry: 3 fractional works · 2.5% of its workAnalytical Chemistry: 0 fractional works · 0.2% of its workEnergy: 2 fractional works · 1.9% of its workRenewable Energy, Sustainability and the Environment: 2 fractional works · 1.9% of its workMaterials Science: 1 fractional works · 0.8% of its workMaterials Chemistry: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemical Engineering: 1 fractional works · 0.6% of its workCatalysis: 1 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.1% of its workLife Sciences: 28 fractional works · 26.6% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 13.3% of its workMolecular Biology: 10 fractional works · 9.2% of its workGenetics: 2 fractional works · 2.0% of its workCancer Research: 1 fractional works · 0.7% of its workCell Biology: 1 fractional works · 0.5% of its workBiotechnology: 1 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.5% of its workImmunology and Microbiology: 11 fractional works · 10.5% of its workImmunology: 11 fractional works · 10.1% of its workMicrobiology: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 1.3% of its workCognitive Neuroscience: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 1 fractional works · 0.8% of its workPlant Science: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workSocial Sciences: 10 fractional works · 9.2% of its workDecision Sciences: 3 fractional works · 2.6% of its workManagement Science and Operations Research: 2 fractional works · 1.8% of its workInformation Systems and Management: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 2 fractional works · 2.2% of its workEconomics and Econometrics: 2 fractional works · 2.1% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 2.0% of its workPolitical Science and International Relations: 1 fractional works · 0.6% of its workSociology and Political Science: 1 fractional works · 0.6% of its workLaw: 0 fractional works · 0.5% of its workHealth: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPsychology: 2 fractional works · 1.7% of its workSocial Psychology: 1 fractional works · 0.9% of its workClinical Psychology: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 0 fractional works · 0.4% of its workStrategy and Management: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workALL ITS WORKBlueprintMedicines (Unite…106fractional works, 2022-now
Life Sciences27%Physical Sciences30%Health Sciences34%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 25 fields, with their numbers
    1. Medicine3533.0%
    2. Health Professions11.1%
    3. Veterinary00.1%
    4. Nursing00.1%
    1. Engineering76.4%
    2. Computer Science66.1%
    3. Physics and Astronomy55.0%
    4. Environmental Science43.3%
    5. Earth and Planetary Sciences32.9%
    6. Chemistry32.8%
    7. Energy21.9%
    8. Materials Science10.8%
    9. Chemical Engineering10.6%
    10. Mathematics00.1%
    1. Biochemistry, Genetics and Molecular Biology1413.3%
    2. Immunology and Microbiology1110.5%
    3. Neuroscience11.3%
    4. Agricultural and Biological Sciences10.8%
    5. Pharmacology, Toxicology and Pharmaceutics10.7%
    1. Decision Sciences32.6%
    2. Economics, Econometrics and Finance22.2%
    3. Social Sciences22.0%
    4. Psychology21.7%
    5. Arts and Humanities00.4%
    6. Business, Management and Accounting00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.17× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.50× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 10.43× its world share, 11 worksImmunology and Micro…Neuroscience: 0.79× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.00× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 1.80× its world share, 1 worksChemical EngineeringChemistry: 1.77× its world share, 3 worksChemistryComputer Science: 0.79× its world share, 6 worksComputer ScienceEarth and Planetary Sciences: 1.86× its world share, 3 worksEarth and Planetary …Energy: 2.05× its world share, 2 worksEnergyEngineering: 0.43× its world share, 7 worksEngineeringEnvironmental Science: 0.67× its world share, 4 worksEnvironmental ScienceMaterials Science: 0.22× its world share, 1 worksMaterials ScienceMathematics: 0.09× its world share, 0 worksMathematicsPhysics and Astronomy: 2.26× its world share, 5 worksPhysics and AstronomyHealth Professions: 0.42× its world share, 1 worksHealth ProfessionsMedicine: 1.72× its world share, 35 worksMedicineNursing: 0.11× its world share, 0 worksNursingVeterinary: 0.52× its world share, 0 worksVeterinaryArts and Humanities: 0.12× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.11× its world share, 0 worksBusiness, Management…Decision Sciences: 2.68× its world share, 3 worksDecision SciencesEconomics, Econometrics and Finance: 1.01× its world share, 2 worksEconomics, Econometr…Psychology: 0.56× its world share, 2 worksPsychologySocial Sciences: 0.16× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.4×. Every wedge is a field page.

All 25 fields, with their numbers
  1. Immunology and Microbiology10.43×11 works
  2. Decision Sciences2.68×3 works
  3. Biochemistry, Genetics and Molecular Biology2.50×14 works
  4. Physics and Astronomy2.26×5 works
  5. Energy2.05×2 works
  6. Pharmacology, Toxicology and Pharmaceutics2.00×1 works
  7. Earth and Planetary Sciences1.86×3 works
  8. Chemical Engineering1.80×1 works
  9. Chemistry1.77×3 works
  10. Medicine1.72×35 works
  11. Economics, Econometrics and Finance1.01×2 works
  12. Neuroscience0.79×1 works
  13. Computer Science0.79×6 works
  14. Environmental Science0.67×4 works
  15. Psychology0.56×2 works
  16. Veterinary0.52×0 works
  17. Engineering0.43×7 works
  18. Health Professions0.42×1 works
  19. Materials Science0.22×1 works
  20. Agricultural and Biological Sciences0.17×1 works
  21. Social Sciences0.16×2 works
  22. Arts and Humanities0.12×0 works
  23. Nursing0.11×0 works
  24. Business, Management and Accounting0.11×0 works
  25. Mathematics0.09×0 works

Who are the top researchers at Blueprint Medicines (United States)?

Ranked on the quality score, Klaus P. Hoeflich, Beni B. Wolf and Stefanie S. Schalm lead among researchers whose main affiliation is Blueprint Medicines (United States).

  1. 1 Klaus P. Hoeflich United States · #69,697 worldwide 12k citations · 279 works
  2. 2 Beni B. Wolf United States · #96,820 worldwide 11k citations · 243 works
  3. 3 Stefanie S. Schalm United States · #304,451 worldwide 5.4k citations · 61 works
  4. 4 Victoria E. Brown United States · #326,175 worldwide 2.2k citations · 108 works
  5. 5 Lucian DiPietro United States · #514,742 worldwide 1.8k citations · 68 works
  6. 6 Huimin Lin United States · #597,703 worldwide 3.6k citations · 150 works
  7. 7 Alexandra K. Gardino United States · #613,597 worldwide 2.2k citations · 39 works
  8. 8 Alexandra R. Grassian United States · #639,019 worldwide 3.5k citations · 72 works
  9. 9 Erica K. Evans United States · #706,933 worldwide 3k citations · 85 works
  10. 10 Chaoyang Ye United States · #875,696 worldwide 2.7k citations · 84 works
All ranked researchers at Blueprint Medicines (United States)

What are the most cited papers from Blueprint Medicines (United States)?

The most cited paper from Blueprint Medicines (United States) is "Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal" (Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al., 2013), with 16,184 citations. Next come "p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells" (1,041) and "The landscape of kinase fusions in cancer" (989).

Most cited papers
#PaperReleasedCitations
1 Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz et al. · Science Signaling Open access 2 Apr 2013 16,184
2 p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine 8 Jun 2018 1,041
3 The landscape of kinase fusions in cancer Nicolas Stransky, Ethan G Cerami, Stefanie S. Schalm et al. · Nature Communications Open access 10 Sep 2014 989
4 Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles Farshad Farshidfar et al. · Cell Reports Open access236 authors Mar 2017 623
5 Targeting cancer with kinase inhibitors Stefan David Gross, Rami Rahal, Nicolas Stransky et al. · Journal of Clinical Investigation Open access 30 Apr 2015 457
All 59 most cited papers, with filters and sorting

Which keywords describe research at Blueprint Medicines (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Immune Responses, Cytokines, Allergic Disease, Mast Cells, Clinical Trials, Asthma and Chemotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation14▲ 6.1×11 topics
  2. Immune Responses9▲ 57×2 topics
  3. Allergic Disease9▲ 557×1 topic
  4. Cytokines9▲ 28×2 topics
  5. Mast Cells9▲ 557×1 topic
  6. Epidemiology6▲ 1.31×14 topics
  7. Clinical Trials5▲ 7.4×6 topics
  8. Chemotherapy5▲ 6.7×9 topics
  9. Treatment5▲ 3.9×10 topics
  10. Asthma5▲ 46×3 topics
  11. Breast Cancer4▲ 17×4 topics
  12. Metastatic Breast Cancer4▲ 72×2 topics
  13. Allergic Diseases4▲ 70×1 topic
  14. Eosinophils4▲ 70×1 topic
  15. Targeted Therapy4▲ 18×4 topics
  16. Prognostic Factors4▲ 8.7×9 topics
  17. Quality of Life4▲ 2.6×6 topics
  18. CDK4/6 Inhibitors4▲ 127×1 topic
  19. Immunotherapy4▲ 4.9×11 topics
  20. Palbociclib4▲ 127×1 topic
  21. Cancer Therapy4▲ 6.1×8 topics
  22. Nonlinear Dynamics3▲ 14×3 topics
  23. Diagnosis3▲ 3.2×9 topics
  24. Metastasis3▲ 7.6×4 topics
  25. Management3▲ 3.2×4 topics
  26. Synchronization3▲ 21×2 topics
  27. Treatment Guidelines2▲ 11×2 topics
  28. Autoantibodies2▲ 9.8×4 topics
  29. Autoimmune2▲ 50×2 topics
  30. Chronic Spontaneous Urticaria2▲ 103×1 topic
  31. Urticaria2▲ 103×1 topic
  32. Development2▲ 5.6×4 topics
  33. ALK Inhibitors2▲ 30×1 topic
  34. Chimera States2▲ 72×1 topic
  35. EGFR Mutations2▲ 30×1 topic
  36. Genome Analysis2▲ 19×2 topics
  37. Reaction-Diffusion Model2▲ 72×1 topic
  38. Genetic Variants2▲ 10×2 topics
  39. Mutation2▲ 10×2 topics
  40. Cell Cycle2▲ 48×2 topics

Which research topics does Blueprint Medicines (United States) publish most on?

By volume in 2022-now: Mast cells and histamine, Asthma and respiratory diseases, Advanced Breast Cancer Therapies and Urticaria and Related Conditions.

  1. 1 Mast cells and histamine Immunology 9 works
  2. 2 Asthma and respiratory diseases Physiology 4 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
  4. 4 Urticaria and Related Conditions Rheumatology 2 works
  5. 5 Nonlinear Dynamics and Pattern Formation Computer Networks and Communications 2 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  7. 7 Lung Cancer Research Studies Oncology 2 works
  8. 8 Cancer-related Molecular Pathways Oncology 2 works
  9. 9 Marine and coastal ecosystems Oceanography 1 works
  10. 10 Microbial Community Ecology and Physiology Ecology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.7%not open33.3%

World: 40% of research is openly available.

with international co-authors19.2%domestic only80.8%

World: 18% is written across borders.

How has Blueprint Medicines (United States)'s research output changed?

Output in 2022-2025 was 33% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Blueprint Medicines (United States) as a percentage of every work published that year, 0.00026% in 2024.

still counting0.00020%0.00040%Blueprint Medicines (United States)0.00021% in 202519801990200020102020

Fractional works of Blueprint Medicines (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Share Blueprint Medicines (United States)'s ranking

Blueprint Medicines (United States) on Science Explorer

A card with Blueprint Medicines (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Blueprint Medicines (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.